Fluidigm Targets $48.7M in Net Proceeds from Public Offering
August 16, 2012
Fluidigm Targets $48.7M in Net Proceeds from Public Offering
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Fluidigm Raises $56.1M in Public Offering
August 21, 2012 / GenomeWeb Daily News - Saskatchewan Disease Control Lab to Use Fluidigm BioMark in Infectious Disease Testing
May 9, 2013 / PCR Insider - Single-cell Genomics Continues to Drive Growth at Fluidigm as Q1 Revenues Rise 33 Percent
May 2, 2013 / PCR Insider - Fluidigm Reports 33 Percent Spike in Q1 Revenues
May 2, 2013 / GenomeWeb Daily News - Fluidigm Developing HLA Typing Prep System for German Bone Marrow Donor Database
May 1, 2013 / GenomeWeb Daily News